PHH

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.11
Percentage change -9.57	%

Held by: PGJ

Scroll to Statements

Index	-	P/E	17.96	EPS (ttm)	0.06	Insider Own	81.71%	Shs Outstand	25.00M	Perf Week	-97.44%
Market Cap	27.42M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.82M	Perf Month	-94.44%
Enterprise Value	26.94M	PEG	-	EPS next Q	-	Inst Own	0.19%	Short Float	5.71%	Perf Quarter	-92.35%
Income	0.48M	P/S	11.52	EPS this Y	-	Inst Trans	-35.87%	Short Ratio	0.22	Perf Half Y	-79.16%
Sales	2.38M	P/B	17.26	EPS next Y	-	ROA	17.89%	Short Interest	0.28M	Perf YTD	-83.47%
Book/sh	0.06	P/C	49.86	EPS next 5Y	-	ROE	38.00%	52W High	41.49 -97.49%	Perf Year	-
Cash/sh	0.02	P/FCF	31.52	EPS past 3/5Y	-65.38% -	ROIC	30.70%	52W Low	1.06 -1.89%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	32.86	Sales past 3/5Y	11.40% -	Gross Margin	91.80%	Volatility	311.29% 80.89%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.32	EPS Y/Y TTM	-91.85%	Oper. Margin	33.32%	ATR (14)	3.82	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.09	Sales Y/Y TTM	-3.14%	Profit Margin	20.09%	RSI (14)	26.26	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.15	EPS Q/Q	-94.14%	SMA20	-95.78%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.05	Sales Q/Q	40.59%	SMA50	-94.45%	Rel Volume	3.44	Prev Close	1.15
Employees	31	LT Debt/Eq	0.03	Earnings	-	SMA200	-91.51%	Avg Volume	1.24M	Price	1.04
IPO	Dec 27, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	4,266,984	Change	-9.57%

Apr-30-25 06:21AM	Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 (Insider Monkey)
Mar-31-25 05:03AM	Park Ha Biological Technology: Growth Potential And Profitability Concerns (Seeking Alpha)
Mar-25-25 09:24AM	Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? (InsiderMonkey) -11.83%
Mar-09-25 06:02PM	Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week (Insider Monkey)
Jan-06-25 08:00AM	D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering (GlobeNewswire) +7.05%
05:30PM	Loading…
Dec-30-24 05:30PM	Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering (GlobeNewswire) +19.16% +29.69%
Dec-26-24 09:46PM	Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering (GlobeNewswire)

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. It operates through the Product Sales and Franchise Service segments. The company was founded by Xiao Qiu Zhang on October 11, 2022 and is headquartered in Wuxi, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Park Ha Biological Technology Co Ltd

Upgrade your FINVIZ experience